SCHEMBL29566970

SCHEMBL29566970

CNC(=O)c1ccc(Oc2cc(-c3c(C)cccc3C)nc(NS(=O)(=O)c3cnn(C)c3)n2)cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.37
▸ GRM5 P41594 1/20 0.35
▸ PIK3CD O00329 6/20 0.34
▸ PIK3CG P48736 6/20 0.34
▸ PIK3CB P42338 5/20 0.34
▸ MTOR P42345 1/20 0.34
▸ EGFR P00533 2/20 0.34
▸ FGFR1 P11362 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ PIK3CA P42336 5/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ PARP1 P09874 1/20 0.33
▸ AURKA O14965 1/20 0.33
▸ AURKB Q96GD4 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ CDK19 Q9BWU1 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309468 1.00 HRH3 (0.37) HRH3GRM5PIK3CDPIK3CGPIK3CB
SCHEMBL26810272 0.89 EGFR (0.38) EGFRFGFR1KDRAURKAAURKB
SCHEMBL29566346 0.88 HTR1A (0.36) PIK3CDPIK3CGPIK3CBMTOREGFR
SCHEMBL24309393 0.88 HTR1A (0.36) PIK3CDPIK3CGPIK3CBMTOREGFR
SCHEMBL26810187 0.87 SLC6A9 (0.38) PIK3CDPIK3CGPIK3CBEGFRFGFR1
SCHEMBL29567200 0.87 F10 (0.43) EGFRFGFR1KDRSMN1; SMN2
SCHEMBL24310795 0.87 F10 (0.43) EGFRFGFR1KDRSMN1; SMN2
SCHEMBL26814536 0.87 PIK3CD (0.36) PIK3CDPIK3CGPIK3CBMTORTSHR
SCHEMBL24309639 0.86 HRH3 (0.41) HRH3EGFRFGFR1KDRSCN9A
SCHEMBL29566701 0.86 HRH3 (0.41) HRH3EGFRFGFR1KDRSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback